http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008116592-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4a9193719c65cc356e7347b3363efdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ed263d7e7da274fd43626a040779064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a3a346ef2a4cd8cc09f9b33439ec65c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55734dc37de76a25206509a079df5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3da588759d4808d228d61aa236a5d8ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19bf4c2d57d2eb1286090270bb9a73f6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-988
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
filingDate 2008-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9269b3c7ecdb2b0a4dd53709259c2a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c8b5789a5e6a811f457c8c1f235b74b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9a94a31362c5be449aa1942568b1edf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7311dd6526d46b78c2e4fdebb3a6107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fa5231fe1e73005b104aa4f5f1c9f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08dca5ae742ef77e0374299f1cf92d51
publicationDate 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008116592-A1
titleOfInvention Apex as a marker for lung cancer
abstract The present invention relates to the assessment of lung cancer. It discloses the use of protein APEX in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring APEX in said sample. Measurement of APEX can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102435748-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102507951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102507951-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8951738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526976-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013344505-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012528303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102435748-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101930004-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012508385-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9518990-B2
priorityDate 2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9747971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02076280-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129741655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127380360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128912572

Total number of triples: 49.